Source / episode info
- **Episode:**508
- **Title:**Divine Intervention Episode 508: The Clutch Sickle Cell Disease Podcast (for Step 1-3) Part 2
- **Published:**2024-02-02
- Source:Episode page
One-liner
This episode provides a comprehensive review of Sickle Cell Disease management, emphasizing the role of hydroxyurea and prophylactic care, while detailing acute complications like ACS/FES, chronic organ damage (iron overload, renal failure), and key epidemiological differences in stroke presentation.
High-yield summary
- Pathophysiology: SCD involves polymerization of Hemoglobin S (HbS) under hypoxic conditions, leading to rigid sickling, blood stasis, vaso-occlusion, hypercoagulability, and end-organ damage.
- Primary Prevention: Cornerstone therapy includes Hydroxyurea (increases HbF) and prophylactic antibiotics (e.g., Penicillin).
- Acute Complications & Management: Suspect an Exchange Transfusion for multiple infarctions, Acute Chest Syndrome (ACS), or Fat Embolism Syndrome (FES); however, always treat the primary issue first (e.g., PE before exchange transfusion).
- Chronic Organ Damage: Frequent transfusions cause iron overload, necessitating chelation therapy with agents like Deferoxamine. SCD patients also require prophylactic ACE inhibitors due to increased risk of proteinuria and hyperfiltration injury.
- Stroke Epidemiology: The most common stroke type in children is Ischemic; the most common stroke type in adults is Hemorrhagic.
- Infection/Bone Health: Osteomyelitis is most commonly caused by Salmonella, and prophylactic vaccines (Pneumococcal, Influenza) are mandatory.
Learning objectives
- Describe the pathophysiology of sickling and vaso-occlusion in SCD.
- Identify key prophylactic treatments for SCD, including hydroxyurea and antibiotics.
- Differentiate between acute complications requiring exchange transfusion (ACS vs FES).
- Recognize the signs and management principles for chronic organ damage (iron overload, renal injury) in SCD.
- Apply knowledge of stroke epidemiology differences based on patient age group (pediatric vs adult).